Iscaffpharma

Curing cancer by generating precision medicine

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Göteborg, Sweden
  • Currency SEK
  • Founded September 2017
  • Employees 3
  • Incorporation Type LLC
  • Website iscaffpharma.com

Company Summary

Cancer remains a major cause of disease and death despite efforts from research the translatability from pre-clinical to clinical results remain poor. Iscaffpharma can change that. We have unique technology that decodes the human cancer microenvironment. The technology is used for:
- Target and drug discovery
- Drug screening in human tumor samples or synthetic replicas
- Personalized medicine

Team

  • Per Setterberg
    CEO

    Experienced in business development from several start-ups. Demonstrated history of working in the information technology and health care industry. CEO at Iscaffpharma. Skilled in fundraising, Marketing Management, Communication, Sales Management, Medical Devices and Pharmaceuticals. Bachelor of Economics from School of business Gothenburg University and Bachelor of law from Lunds University. Member of the board at Strandbacka Inn.

  • Professor Göran Landberg
    CSO

    MD and senior consultant in pathology, Professor at University of Gothenburg Sweden

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free